Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
Clinical trial NCT04377659 · TERMINATED
Trial details
- NCT number
- NCT04377659
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2022-10-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.